Rapidly progressive periodontitis: a distinct clinical condition
RC Page, LC Altman, JL Ebersole… - Journal of …, 1983 - Wiley Online Library
We report radiographic, clinical, historical, and laboratory observations on seven patients
selected to illustrate the features and characteristics of rapidly progressive periodontitis, with …
selected to illustrate the features and characteristics of rapidly progressive periodontitis, with …
Effects of corticosteroids on eosinophil chemotaxis and adherence
LC Altman, JS Hill, WM Hairfield… - The Journal of clinical …, 1981 - Am Soc Clin Investig
Therapeutic doses of corticosteroids frequently induce eosinopenia; however, the
mechanism(s) involved remain obscure. To investigate this question, we studied the effects of …
mechanism(s) involved remain obscure. To investigate this question, we studied the effects of …
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
LC Altman, Z Munk, J Seltzer, N Noonan… - Journal of allergy and …, 1998 - Elsevier
Background: The cysteinyl leukotrienes are important mediators of bronchial asthma. The
clinical effect of montelukast, a potent cysteinyl leukotriene–receptor antagonist, was …
clinical effect of montelukast, a potent cysteinyl leukotriene–receptor antagonist, was …
Severe recurrent bacterial infections associated with defective adherence and chemotaxis in two patients with neutrophils deficient in a cell-associated glycoprotein
TJ Bowen, HD Ochs, LC Altman, TH Price… - The Journal of …, 1982 - Elsevier
We studied two patients with delayed umbilical cord detachment, recurrent bacterial infections,
inability to form pus, rapidly progressive periodontitis, and persistent leukocytosis. The …
inability to form pus, rapidly progressive periodontitis, and persistent leukocytosis. The …
Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD 4) receptor antagonist, in patients with chronic asthma
TF Reiss, LC Altman, P Chervinsky, A Bewtra… - Journal of Allergy and …, 1996 - Elsevier
BACKGROUND: Cysteinyl leukotrienes mediate signs and symptoms of asthma. In a double-blind,
placebo-controlled, crossover study, a new potent and specific cysteinyl leukotriene (…
placebo-controlled, crossover study, a new potent and specific cysteinyl leukotriene (…
Pro-and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts
…, S Potter-Perigo, C Tsoi, LC Altman… - American journal of …, 2004 - atsjournals.org
Hyaluronan (HA) is an important constituent of the extracellular matrix and accumulates during
inflammatory lung diseases like asthma. Little is known about the factors that regulate HA …
inflammatory lung diseases like asthma. Little is known about the factors that regulate HA …
Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion
…, KR Braun, TS Wilkinson, LC Altman… - American journal of …, 2010 - atsjournals.org
Viral infections are known to exacerbate asthma and other lung diseases in which chronic
inflammatory processes are implicated, but the mechanism is not well understood. The viral …
inflammatory processes are implicated, but the mechanism is not well understood. The viral …
Leukotriene B4 Production by the Human Alveolar Macrophage: A Potential Mechanism for Amplifying Inflammation in the Lung
TR Martin, LC Altman, RK Albert… - American Review of …, 1984 - atsjournals.org
Leukotriene B 4 (LTB 4 ) is a lipoxygenase product off arachidonic acid that has potent
chemotactlc activity for blood leukocytes. To assess the potential role off LTB 4 in lung …
chemotactlc activity for blood leukocytes. To assess the potential role off LTB 4 in lung …
The toxicity of constituents of cedar and pine woods to pulmonary epithelium
GH Ayars, LC Altman, CE Frazier, EY Chi - Journal of allergy and clinical …, 1989 - Elsevier
Occupational exposure to cedar and pine woods and pine resin (colophony) can cause
asthma and chronic lung disease. Prior studies suggest that plicatic and abietic acids are …
asthma and chronic lung disease. Prior studies suggest that plicatic and abietic acids are …
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis
…, F Aleman, C Boylan, LC Altman… - European …, 2017 - Eur Respiratory Soc
A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis | European
Respiratory Society Skip to main content Main menu Home Current issue ERJ Early View Past …
Respiratory Society Skip to main content Main menu Home Current issue ERJ Early View Past …